What is the recommended prophylaxis for pertussis (whooping cough)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pertussis Prophylaxis Recommendations

Azithromycin is the first-line antibiotic for pertussis post-exposure prophylaxis due to its once-daily dosing, excellent tolerability, and shorter treatment duration compared to other options. 1

Recommended Prophylactic Regimens

First-Line Treatment: Azithromycin

  • Adults: 500 mg on day 1, then 250 mg daily for 4 days (5 days total)
  • Children: 10 mg/kg on day 1, then 5 mg/kg daily for 4 days (5 days total) 1

Second-Line Treatment: Clarithromycin

  • Adults: 500 mg twice daily for 7 days
  • Children: 15 mg/kg/day in 2 divided doses for 7 days (maximum 1 g/day) 1

Third-Line Treatment: Erythromycin

  • Adults: 500 mg four times daily for 14 days
  • Children: 40-50 mg/kg/day in divided doses for 14 days 2, 3

Alternative (when macrolides cannot be used): Trimethoprim-Sulfamethoxazole

  • Adults: Trimethoprim 320 mg/day, sulfamethoxazole 1,600 mg/day in 2 divided doses for 14 days
  • Children (>2 months): Trimethoprim 8 mg/kg/day, sulfamethoxazole 40 mg/kg/day in 2 divided doses for 14 days 1

Key Considerations for Prophylaxis

Timing and Effectiveness

  • Prophylaxis is most effective when initiated within 2 weeks of exposure 1
  • Close contacts should receive the same antibiotic regimens as for treatment, regardless of vaccination status 1

Who Should Receive Prophylaxis

  • Household contacts of pertussis cases 2, 1
  • Individuals at high risk of severe pertussis (infants, pregnant women in third trimester, immunocompromised persons) 4
  • Individuals who have close contact with high-risk persons 4

Isolation Recommendations

  • Patients with pertussis should be isolated at home and away from work or school for 5 days after starting antibiotic therapy 1
  • Healthcare workers with pertussis should be restricted from work during the first 5 days of antimicrobial therapy 1

Advantages of Newer Macrolides Over Erythromycin

  1. Improved Tolerability:

    • Erythromycin causes significant gastrointestinal side effects (epigastric distress, abdominal cramps, nausea, vomiting, diarrhea) 1
    • Azithromycin and clarithromycin have lower incidence of GI side effects 1
  2. Simplified Dosing:

    • Erythromycin requires four-times-daily dosing, reducing compliance 1, 3
    • Azithromycin (once daily) and clarithromycin (twice daily) offer improved dosing regimens 1
  3. Safety Concerns:

    • Erythromycin is associated with infantile hypertrophic pyloric stenosis in infants under 1 month 1
    • Erythromycin inhibits cytochrome P450 enzymes, leading to potentially serious drug interactions 1

Important Caveats and Pitfalls

  • Trimethoprim-sulfamethoxazole is contraindicated in infants under 2 months, pregnant women, and nursing mothers 1
  • Antibiotics are intended to prevent transmission of pertussis and do not shorten the disease course or improve symptoms in the infected individual 4
  • Vaccination remains the most effective prevention strategy against pertussis 2, 1, 5
  • Neither vaccination nor natural disease confers lifelong immunity; immunity wanes after 5-10 years 2
  • Cocooning (vaccinating close contacts of high-risk individuals) is no longer recommended as the primary strategy since immunized patients can still contract and transmit pertussis 4

Vaccination Recommendations

  • Children: 5 doses of DTaP vaccine at ages 2,4,6,15-18 months, and 4-6 years 2, 1
  • Adolescents and Adults: At least one dose of Tdap 4
  • Pregnant Women: Tdap between 27-36 weeks' gestation with each pregnancy to provide immunity to the newborn 4

References

Guideline

Antibiotic Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pertussis: Common Questions and Answers.

American family physician, 2021

Research

Prevention of pertussis through adult vaccination.

Human vaccines & immunotherapeutics, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.